🇺🇸 FDA
Patent

US 11680079

Nucleic acid aptamers to treat histone-induced disease states

granted A61KA61K9/0019A61K9/007

Quick answer

US patent 11680079 (Nucleic acid aptamers to treat histone-induced disease states) held by The United States Government as Represented by The Department of Veteran Affairs expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States Government as Represented by The Department of Veteran Affairs
Grant date
Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K9/0019, A61K9/007, A61P, A61P29/02